Actavis Group News Today

/PRNewswire/ -- IONETIX, a leading cyclotron technology and isotope manufacturing company, is pleased to announce the appointment of Douglas Boothe to its...

Investors often find stocks with momentum attractive because they have shown a recent trend of strong performance. The belief is that this trend may continue, offering the potential for profitable...

Elite Pharmaceuticals, Inc. Appoints Carter Ward as Chief Financial ...

Disclosure under Regulation 30 of the SEBI Regulations, 2015 The Board of Directors of the Company at its meeting held on May 10, 2023, has inter alia approved the following: ... | May 10, 2023

THE FOLLOWING PEOPLE ARE CANDIDATES FOR ELECTION AS BOARD DIRECTORS AT KVIKA BANKI´S ANNUAL GENERAL MEETING TO BE HELD ON 30 MARCH... | March 27, 2023

Louboutin v. YSL - Christian Louboutin (“Louboutin”), the designer of the famous red bottom shoes, filed a trademark infringement lawsuit against fashion house Yves Saint...

Christian Louboutin, the designer of the famous red bottom shoes, filed a trademark infringement lawsuit against fashion house YSL claiming YSL infringed on its red sole trademark by selling a monochrome dress shoe that was entirely red.

The generic pharmaceuticals company, Actavis Group, this week marketed Olanzapine tablets across several European countries.

Actavis Group and Japan’s ASKA Pharmaceutical have formally signed an agreement establishing a joint company: Actavis ASKA K.K. with its head office in Tokyo. The preliminary agreement was signed last November.

/PRNewswire/ -- Mallinckrodt plc ("Mallinckrodt" or the "Company") today announced that it has successfully completed its reorganization process, emerged from...